鲁商福瑞达：合成生物领航医药美妆 “四链”融合锻造健康生态

Core Viewpoint - Furuida, a state-controlled listed company under Lushang Group, is recognized for its innovation-driven industrial upgrades in the pharmaceutical and cosmetics sectors, having formed a collaborative innovation consortium and achieved significant technological breakthroughs [1][3]. Group 1: Innovation and Collaboration - Furuida has been a leader in the hyaluronic acid industry for over 30 years, addressing challenges such as limited core technologies and low competitiveness of high-value products through open collaboration [3]. - The company has established the "Shandong Synthetic Biology and Green Manufacturing Innovation Consortium," integrating top universities and research institutions to tackle common technological challenges in cutting-edge fields like cell factories and green catalysis [3]. - Furuida's research team has developed a nanocrystal/bioadhesive transmembrane delivery technology that resolves critical issues in drug absorption and targeting, resulting in 29 national invention patents and the launch of 33 new drug products, generating an annual output value exceeding 1 billion yuan [4]. Group 2: Ecosystem and Market Position - Furuida promotes a "four-chain" integration model to bridge gaps between talent, education, innovation, and industry, enhancing the flow of innovation elements [6]. - The company has implemented a collaborative investment and shared outcome model, creating a full chain from raw material research to end products, and has initiated the "Hyaluronic Acid+" industry ecosystem plan, successfully incubating 19 new brands [6]. - Since the 14th Five-Year Plan, Furuida has solidified its leading position in the hyaluronic acid sector, establishing a research cluster with 4 national and 17 provincial platforms, and has undertaken over 30 major scientific projects, accumulating nearly 400 authorized patents [6].